Skip to main content

Breast cancer screening and overdiagnosis.

Bulliard JL, Beau AB, Njor S, et al. Breast cancer screening and overdiagnosis. Int J Cancer. 2021;149(4): 846-853. doi: 10.1002/ijc.33602.

August 11, 2021
Bulliard J‐L, Beau A‐B, Njor S, et al. Int J Cancer. 2021;149(4):846-853.

Overdiagnosis of breast cancer and the resulting overtreatment can cause physical, emotional, and financial harm to patients. Analysis of observational data and modelling indicates overdiagnosis accounts for less than 10% of invasive breast cancer in patients aged 50-69. Understanding rates of overdiagnosis can assist in ascertaining the net benefit of breast cancer screening.